Cancer evolution: Darwin and beyond. (2021)

First Author: Vendramin R
Attributed to:  Enhancing immunogenicity in non-viral low mutation burden tumours funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.15252/embj.2021108389

PubMed Identifier: 34459009

Publication URI: http://europepmc.org/abstract/MED/34459009

Type: Journal Article/Review

Volume: 40

Parent Publication: The EMBO journal

Issue: 18

ISSN: 0261-4189